For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]

On This Page Date: November 16, 2023 Time: 1:00 PM – 2:30 PM ET Visit CDER Small Business and Industry Assistance Page ABOUT THIS EVENT In […]

Summary Company Announcement Date: September 29, 2023 FDA Publish Date: October 03, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential Presence of Oxycodone […]

Issued by: Guidance Issuing Office Office of Regulatory Affairs Center for Food Safety and Applied Nutrition BACKGROUND: This policy guide sets forth the position of FDA […]

Notice to Industry: Bioresearch Monitoring Information System (BMIS) Data In order to foster transparency and encourage information sharing within the clinical research community, FDA’s Center for […]

Summary Company Announcement Date: October 02, 2023 FDA Publish Date: October 02, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential Presence of Glass […]

Summary Company Announcement Date: September 29, 2023 FDA Publish Date: October 02, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential Contamination with Microbacterium […]

Acetadote (acetylcysteine) Generic products containing acetylcysteine Overdose FDA is evaluating the need for regulatory action. Aromatase inhibitors Arimidex (anastrozole) Aromasin (exemestane) Femara (letrozole) Generic products containing […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name James B. Carty Shot of Joy LLC 1450 2nd Street, #400Santa Monica, CA 90401United States [email protected] Issuing […]